COVID-19 causes the immune system to go rogue and harm the body, researchers say

Researchers have found that in some people with severe COVID-19, the immune system goes rogue and attacks one of its own key defenses instead of fighting the coronavirus.

COVID-19 deaths falling but Americans 'must remain vigilant'

U.S. deaths from COVID-19 are falling again as the nation continues to recover from the devastating winter surge, a trend that experts are cautiously hopeful will accelerate as more vulnerable people are vaccinated.

Georgia childcare industry expected to get a boost from COVID-19 relief bill

The Coronavirus relief bill that was signed by President Joe Biden on Monday will pump more than a billion dollars into things  like daycares and programs for young children in the state. 

Biden directs states to make all adults eligible for COVID-19 vaccine by May 1

President Joe Biden signed the landmark $1.9 trillion COVID-19 relief bill into law on Thursday, which will send $1,400 direct payments to many adults and extend emergency unemployment benefits.

Fayette County educators, staff get first dose of COVID-19 vaccine

The Fayette County School District joins a number of other Georgia school systems, in opening a vaccination clinic for its employees. The site opened Thursday, at Fayette County High School.

CDC finds women report worse side effects from COVID-19 vaccine than men

According to data from the CDC, of the first 6,994 people who reported side effects after receiving a COVID-19 vaccine, 79% were women.

Georgians 55 and up, high-risk to get their turn at COVID-19 vaccination

When Glen Sarvady's wife, Andy, a teacher, got her first COVID-19 shot, Tuesday, he thought it would be another 6 weeks until he would be eligible for the vaccine. That changed quickly on Wednesday.

Biden wants all adults vaccine-eligible by May 1

President Joe Biden will use his first prime-time address on Thursday night to announce that he is directing states to make all American adults eligible for a coronavirus vaccine no later than May 1.

Novavax vaccine has 96% efficacy against original COVID-19 strain, 55.4% against South Africa variant

Vaccine developer Novavax announced on Thursday that its vaccine offers high levels of protection against the original coronavirus strain that causes COVID-19, but the vaccine’s efficacy is diminished by some coronavirus variants, including one that originated in South Africa.